Correlation Between Karyopharm Therapeutics and Vera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Vera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Vera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Vera Therapeutics, you can compare the effects of market volatilities on Karyopharm Therapeutics and Vera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Vera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Vera Therapeutics.
Diversification Opportunities for Karyopharm Therapeutics and Vera Therapeutics
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Karyopharm and Vera is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Vera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vera Therapeutics and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Vera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vera Therapeutics has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Vera Therapeutics go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Vera Therapeutics
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to under-perform the Vera Therapeutics. In addition to that, Karyopharm Therapeutics is 1.25 times more volatile than Vera Therapeutics. It trades about -0.65 of its total potential returns per unit of risk. Vera Therapeutics is currently generating about -0.29 per unit of volatility. If you would invest 4,727 in Vera Therapeutics on September 25, 2024 and sell it today you would lose (535.00) from holding Vera Therapeutics or give up 11.32% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Karyopharm Therapeutics vs. Vera Therapeutics
Performance |
Timeline |
Karyopharm Therapeutics |
Vera Therapeutics |
Karyopharm Therapeutics and Vera Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Karyopharm Therapeutics and Vera Therapeutics
The main advantage of trading using opposite Karyopharm Therapeutics and Vera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Vera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vera Therapeutics will offset losses from the drop in Vera Therapeutics' long position.Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Vera Therapeutics vs. Fate Therapeutics | Vera Therapeutics vs. Caribou Biosciences | Vera Therapeutics vs. Karyopharm Therapeutics | Vera Therapeutics vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |